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httpcense.Abstract Background: Many studies have suggested the role of vitamin D deﬁciency in both T-
helper1 and T-helper2 diseases. The existence of associations of vitamin D with asthma and allergy
remains uncertain. While some suggest that vitamin D may be protective, others suggest that vita-
min D supplementation may increase the risk of allergy.
Aim of the work: The aim of the study was to evaluate the state of vitamin D in asthmatic
patients and its potential relationship with asthma phenotypes.
Patients and methods: This study was conducted on 66 nonsmoker asthmatic patients and 30
healthy controls. Serum 25-hydroxy vitamin D3 levels were determined and compared between the
two groups. The relationship between serum vitaminD levels and asthma phenotypes were examined.
Results: VitaminD level was signiﬁcantly lower in asthmatic patients than in control group, in asth-
matic patients, vitamin D levels had a signiﬁcant positive correlation with FEV1% predicted and a sig-
niﬁcant negative correlation with body mass index, the number of atopic patients was signiﬁcantly
higher in bronchial asthma patients with vitamin D insufﬁciency than those with sufﬁcient vitamin D.
Conclusion: Vitamin D deﬁciency was highly prevalent in asthmatic patients and it was associated
with atopy and asthma severity.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.499 6289.
.com (R. Eman Shebl).
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Asthma has been recognized as a typical complex disease
with a high number of factors modulating the expression of
asthma-related phenotypes and/or outcomes [1]. The innate
and adaptive immune systems play an important role in the
pathogenesis of asthma. Many genes involved in inﬂammation
and immunoregulation pathways have been associated with
asthma. The immune system is complex in nature with multiple
redundant and interfering pathways. Recently, the vitamin D
pathway has emerged as a new pathway contributing to the
outcome of immune responses [2].is. Production and hosting by Elsevier B.V.
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202 R. Eman Shebl et al.Vitamin D is a nutrient and a hormone that can be ob-
tained from a few natural foods and fortiﬁed foods and it
can be generated endogenously from sunlight exposure via a
photosynthetic mechanism in the skin. Vitamin D deﬁciency
has been reported in many populations, even in those living
in areas with abundant sun exposure. 25-Hydroxyvitamin D
[25(OH)D] is the major circulating form of vitamin D, and
its concentration in serum has been thought to reﬂect the sta-
tus of vitamin D [3]. Although there is no consensus regarding
optimal 25(OH) Dserum levels, based on epidemiologic stud-
ies, a desirable level of serum vitamin D, i.e., 25(OH)D, for
general health is at least 30–40 ng/mL (75–100 nmol/L) [4]. Re-
cently the effects of vitamin D as a hormone have gained atten-
tion. Vitamin D appears to have regulatory effects on every
part of the immune system, with vitamin D deﬁciency being
linked to an array of immunologically based diseases. Because
Vitamin D promotes steroid sensitivity in the body and can
down regulate an inﬂammatory state via gene expression and
cytokine production, its action in this case could be directly
on the airway. Vitamin D receptors are present in the airways
and are thought to inhibit proinﬂammatory cytokines, with ef-
fects on CD4+ T cells, interleukin-2, interferon-gamma, and
macrophages. A deﬁciency of Vitamin D could be associated
with an inability to switch off the inﬂammatory state, follow-
ing an acute inhalational insult, with up regulation of prosta-
glandin, leukotrienes, macrophages, and T cell activity and
recruitment [2,5].
There have been numerous studies looking at vitamin D
status in association with various lung diseases focusing on
asthma, chronic obstructive pulmonary disease (COPD), cystic
ﬁbrosis (CF), and respiratory infections. These studies have
demonstrated a high prevalence of vitamin D deﬁciency in
their participants [6]. Vitamin D deﬁciency has been associated
with lower lung function in COPD and CF patients [7]. Other
studies have shown an association between vitamin D deﬁ-
ciency and infections such as Mycobacterium tuberculosis
[8,9] and upper respiratory tract infections [10–12]. The exis-
tence of associations of vitamin D with asthma and allergy re-
mains uncertain. While some suggest that higher maternal
intake of vitamin D during pregnancy was associated with a
decreased risk of recurrence of wheezing in young children,
others suggest that vitamin D supplementation may increase
the risk of allergy [13] therefore, the aim of this study was to
evaluate the state of vitamin D in asthmatic patients and its
potential relationship with asthma phenotypes.Patients and methods
Patients
This study included 66 newly diagnosed bronchial asthma pa-
tients (34 females and 32 males) with a mean age of
(37.8 ± 10) who attended outpatient clinic between July
2011and July 2012 after giving written informed consent
and 30 healthy control without history of any allergic disor-
ders (16 females and 14 males). Asthma was diagnosed by
history which included episodic respiratory symptoms and
reversible airﬂow obstruction (documentation of reversibility
of FEV1 and/or FVC by 12% or an increase of FEV1 by
200 cc either spontaneously or after inhalation of 400 lg of
salbutamol) [14].Exclusion criteria
Smokers, and patients who had a co-morbid disease in addi-
tion to bronchial asthma that could affect vitamin D serum
levels were excluded. Such diseases included rheumatoid
arthritis, cystic ﬁbrosis, multiple sclerosis, ulcerative colitis,
crohn’s disease, celiac disease, osteomalacia, sarcoidosis, thy-
roid dysfunctions, and individuals who had received medica-
tions including systemic corticosteroids, barbiturates,
bisphosphonates, sulfasalazine, omega3 and vitamin D com-
ponents such as calcium-D.
Methods
The following was done for all patients:
 Complete medical history.
 General and local chest examination.
 Plain postero-anterior chest X-ray.
 Laboratory investigations (total and differential blood cells
count, ESR, renal, hepatic function tests and fasting blood
sugar).
 Spirometry performed according to American Thoracic
Guidelines (before and after inhalation of 400 lg of salbu-
tamol) [15] by using Chestgraph HI-701 spirometer.
 Body mass index (BMI) was calculated from measured
height and weight.
 Eosinophils in blood andsputum: eosinophil’s count in blood
was measured using sysmex kx-21, while in sputum was
assessed as follows:
 Sputum induction: Participants were asked to expectorate a
spontaneous sputum sample or, if unable to do so, they
underwent sputum induction with the inhalation of hyper-
tonic saline (4.5%) through an ultrasonic nebulizer (Such-
atzki, Rennerod, Germany). The nebulization was
continued for at least 10 min and stopped after 15 min or
earlier if a P2 mL sputum sample of good quality was
obtained [16].
 Sputum processing and cell counts: The sputum was
selected from saliva and dispersed using dithiothreitol as
described by Pavord et al. (1997) [16]. The suspension was
ﬁltered, and a total cell count of leukocytes and viability
was performed. Cytospins were stained (May-Grunwald
Geimsa) and a differential cell count was obtained from
400 non-squamous cells [16].
 Allergy skin testing: allergy skin test was performed on the
volar side of the forearm as was previously described [17]
with standardized extracts of common aeroallergen (house
dust, dog hair, cat hair, grass and tree pollen, cotton dust
and mixture of molds). Skin response was measured after
15 min, considering skin wheal diameter. Skin test reaction
was considered positive if the diameter of the skin wheal
was >3 mm, while a wheal diameter <3 mm was deﬁned
as negative response. A >3 mm wheal is a net wheal com-
pared to the negative control. Atopy was deﬁned when a
patient had suggestive history with a signiﬁcant positive
skin test reaction to at least one of the applied aeroallergen
[17].
Table 2 Characteristics of the studied patients according to
vitamin D levels.
Asthmatics
with
insuﬃcient
vitamin
D (N= 29)
Asthmatics
with
suﬃcient
vitamin D
(N= 37)
P value
Vitamin D and phenotypes of bronchial asthma 203 Vitamin D level: Two milliliters of venous blood was
obtained centrifuged; serum was separated and stored at
20 C until assayed. Serum level of 25(OH) D was mea-
sured using the immunodiagnostic enzyme immunoassay
(EIA) developed by immunodiagnostic system kits Ltd. In
this study vitamin D levels were categorized as insufﬁcient
(<30 ng/mL), or sufﬁcient (P30 ng/mL) according to Hol-
ick (2007) [3].BMI (mean ± SD) 31.3 ± 6.3 27 ± 2.1 <0.001
FEV1% 67.8 ± 4 77.6 ± 7 <0.001
Sputum eosinophils % 13.6 ± 5.1 4.7 ± 2.1 <0.001
Asthma severity n (%)
Intermittent 5(17.2%) 11(29.7%)
Mild 6(20.7%) 13(35.1%) <0.05
Moderate 5(17.2%) 8(21.6%)
Severe 13 (44.8%) 5(13.6%)
Table 3 Association of atopy with vitamin D insufﬁciency.
Asthmatics with
insuﬃcient vitamin
D (N= 29)
Asthmatics with
suﬃcient vitamin
D (N= 37)
P
Atopy
Present 17(58.6%) 10(26.4%) <0.05
Absent 12(41.4%) 27(73.6%)Statistical analysis
Statistical analysis was performed with SPSS version19soft-
ware package (SPSS, Inc. Chicago). The results of this study
were analyzed and presented as numbers, percentage or
mean ± standard deviation (SD). Student t test, analysis of
variance (ANOVA) and Chi-square were used for compari-
son between groups. The correlations were analyzed by
Pearson correlation coefﬁcients. A P value less than 0.05
was considered to be signiﬁcant for statistical hypothesis
testing.
Results
A total of 66 asthmatic patients (34 females and 32 males) and
30 controls were enrolled in this study, the mean age of partic-
ipants with asthma was 37.8 ± 10, with mean FEV1%
(73.3 ± 7.6) and BMI (28.8 ± 4.9 kg/m2) (Table 1).
In this study 44% of asthmatic patients suffered from
vitamin D insufﬁciency (25(OH) D< 30 ng/mL) while in con-
trol group vitamin D insufﬁciency was present in 20% of them
(Table 1).
The studied bronchial asthma patients with vitamin D
insufﬁciency had signiﬁcantly higher sputum eosinophils
% and a signiﬁcantly lower FEV1% than bronchial asthma
patients with sufﬁcient vitamin D (Table 2), moreover, there
was a signiﬁcant increase in the number of severe bronchial
asthma patients with vitamin D insufﬁciency (41.4%)
compared with those with sufﬁcient vitamin D (13.6%)
(Table 2).
In this study the presence of atopy was signiﬁcantly higher
in asthmatic patients with vitamin D insufﬁciency (58.6%)
than those without vitamin D insufﬁciency (41.4%) (Table 3).Table 1 Physiological and demographic characteristics of
participants.
Characteristics Asthma
patients
No. = 66
Control group
No. = 30
P
Age (years) 37.8 ± 10 38.2 ± 13 NS
Female 34 51.5% 16 53.3% NS
Male 32 48.5% 14 46.7% NS
BMI (kg/m2) 28.8 ± 4.9 29.2 ± 6.1 NS
FEV1% 73.3 ± 7.6 93.6 ± 8.7 <0.05
FEV1/FVC % 64.8 ± 8.4 87.3 ± 9.2 <0.05
25(OH)D, ng/mL
(mean ± SD)
43.6 ± 16.3 65.8 ± 11.6 <0.05
25(OH)D< 30 ng/mL
(n%)
29(44%) 6(20%) <0.05A signiﬁcant correlation between serum vitamin D with the
FEV1% (P< 0.05) was present in this study (P= 0.000, r
= 0.706) Fig. 1.
In this study a signiﬁcant negative correlation between ser-
um 25(OH) D and BMI (kg/m2) was observed in the studied
asthmatic patients (P= 0.000, r= 0.458) (Fig. 2).
Discussion
The existence of associations of vitamin D with asthma and al-
lergy remains uncertain, therefore, the aim of this study was to
evaluate the state of vitamin D in asthmatic patients and its
potential relationship with asthma phenotypes.
In this study 44% of asthmatic subjects had serum vitamin
D levels <30 ng/mL compared with 20% in the control group
(P< 0.05) which was statistically signiﬁcant. This ﬁnding
agrees with Brehm et al. [18] who found that 25% of asthmatic
patients had serum vitamin D levels <30 ng/mL, and 3.4%
had levels <20 ng/mL and found a strong inverse association
between serum vitamin D levels and asthmatic state. A number
of confounding factors may inﬂuence these relationships; one
is that the subjects with asthma spend more time indoors, so
they may be exposed to less sunlight [18].
The studied bronchial asthma patients with vitamin D
insufﬁciency had signiﬁcantly higher sputum eosinophil %
and a signiﬁcantly lower FEV1% than bronchial asthma pa-
tients with sufﬁcient vitamin D (Table 2), moreover, there
was a signiﬁcant increase in the number of severe bronchial
asthma patients with vitamin D insufﬁciency (41.4%) com-
pared with those with sufﬁcient vitamin D (13.6%) (Table 2).
Vitamin D deﬁciency could be involved in asthma pathogene-
sis through several mechanisms. Vitamin D appears to
have regulatory effects on every part of the immune system,
Figure 2 Correlation between 25(OH) D and BMI.
204 R. Eman Shebl et al.with vitamin D deﬁciency being linked to an array of
immunologically based diseases. Because Vitamin D promotes
steroid sensitivity in the body and can down regulate an
inﬂammatory state via gene expression and cytokine produc-
tion, its action in this case could be directly on the airway.
Vitamin D receptors are present in the airways and are thought
to inhibit proinﬂammatory cytokines, with effects on CD4+ T
cells, interleukin-2, interferon-gamma, and macrophages. A
deﬁciency of Vitamin D could be associated with an inability
to switch off the inﬂammatory state, following an acute inha-
lational insult, with up regulation of prostaglandin, leukotri-
enes, macrophages, and T cell activity and recruitment [19].
A positive correlation was found between 25(OH) D levels
and FEV1% in the studied asthmatic patients in the present
study (Fig. 1) this ﬁnding agrees with that of Damera et al.
(2009) [20] who reported that in patients with asthma, higher
serum 25(OH) D concentrations were associated with higher
FEV1% and explained this ﬁnding by that vitamin D inhibits
the formation of matrix metalloproteinase as well as ﬁbroblast
proliferation and inﬂuences collagen synthesis; these actions
mean that 1,25-dihydroxy vitamin D may inﬂuence tissue
remodeling and probably lung function [20]. It has been shown
that, in addition to affecting immune cells, vitamin D affects
smooth muscle function and proliferation, which has a direct
relevance for lung function in asthma and in airway remodel-
ing [21]. Airway remodeling is an important feature of asthma
and is correlated with airﬂow limitation [22]. Vitamin D inﬂu-
ences airway remodeling by affecting smooth muscle cell
movement, growth, and contractility and by inhibiting trans-
forming growth factor-b and matrix metalloproteinase as well
as ﬁbroblast proliferation [23]. Furthermore, in animal models,
vitamin D has been shown to affect lung development and
maturation in utero and in the immediate postpartum period
[21].
Brehm et al. [24] found an inverse relationship between cir-
culating levels of vitamin D and markers of allergy in asth-
matic patients such as eosinophil count, IgE levels and skin-
test reactivity. These ﬁndings are in line with the results of this
study as the number of atopic asthmatics was signiﬁcantly
higher in asthmatics with insufﬁcient levels of 25(OH) D than
those with sufﬁcient 25(OH) D (Table 3).
In this study there is an inverse relationship between BMI
and vitamin D levels (Fig. 2), a ﬁnding previously reportedFigure 1 Correlation between 25(OH) D and FEV1%.[25]. One of the most signiﬁcant effects of obesity on asthma
relates to phenotype, particularly its association with reduced
response to steroids, both clinically and in vitro [5]. A cross-
sectional study on 616 asthmatic Costa Rican children found
that higher serum 25(OH) D concentrations were associated
with a reduction in the need for anti-inﬂammatory medications
and hospitalization [18]. Others have demonstrated an inverse
correlation between serum 25(OH) D concentrations and the
amount of steroid medication prescribed to asthmatic patients.
This suggests that vitamin D may potentiate the effects of ste-
roids in asthmatic patients and suggests that vitamin D, the
levels of which are reduced in overweight and obese subjects
with asthma, may be one pathway by which obesity and re-
duced steroid response are related [26].
Conclusion
These results showed that vitamin D deﬁciency was highly pre-
valent in asthmatic patients, and there was a direct and a sig-
niﬁcant relationship between vitamin D levels and pulmonary
function test outcomes in asthmatics patients, therefore mea-
suring serum levels of vitamin D could be considered in the
routine assessment of patients with bronchial asthma.
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